METHOD FOR THE SUB-CLASSIFICATION OF PATIENTS SUFFERING FROM PARKINSON DISEASE

The invention relates to the use of extracellular mitochondrial DNA as a quantitative biomarker for the sub-classification of patients suffering from Parkinson disease in the subgroups of familial or idiopathic Parkinson. The invention also relates to a method and to a kit for the sub-classification...

Full description

Saved in:
Bibliographic Details
Main Authors TOLOSA SARRÓ, Eduardo, VILAS ROLÁN,, M. Dolores, PODLESNIY, Petar, TRULLAS OLIVA, Ramón
Format Patent
LanguageEnglish
French
Published 22.06.2017
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the use of extracellular mitochondrial DNA as a quantitative biomarker for the sub-classification of patients suffering from Parkinson disease in the subgroups of familial or idiopathic Parkinson. The invention also relates to a method and to a kit for the sub-classification of patients suffering from Parkinson disease using said biomarker. L'invention concerne l'utilisation d'ADN mitochondrial extracellulaire comme biomarqueur quantitatif pour la sous-classification de patients atteints de la maladie de Parkinson dans les sous-groupes de Parkinson idiopathique ou familial. L'invention concerne également un procédé et un kit pour la sous-classification de patients atteints de la maladie de Parkinson au moyen dudit biomarqueur.
Bibliography:Application Number: WO2016EP81736